Elanco Animal Health
$ 23.68
2.38%
17 Apr - close price
- Market Cap 11,550,645,000 USD
- Current Price $ 23.68
- High / Low $ 24.05 / 23.25
- Stock P/E N/A
- Book Value 13.17
- EPS -0.47
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE -0.04 %
- 52 Week High 27.72
- 52 Week Low 8.33
About
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana.
Analyst Target Price
$28.79
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-05 | 2025-08-07 | 2025-05-06 | 2025-02-24 | 2024-11-07 | 2024-08-08 | 2024-05-08 | 2024-02-26 | 2023-11-07 | 2023-08-07 | 2023-05-09 |
| Reported EPS | 0.13 | 0.19 | 0.26 | 0.37 | 0.14 | 0.13 | 0.3 | 0.34 | 0.08 | 0.18 | 0.18 | 0.45 |
| Estimated EPS | 0.1135 | 0.13 | 0.2 | 0.3044 | 0.1486 | 0.12 | 0.24 | 0.26 | 0.11 | 0.12 | 0.05 | 0.29 |
| Surprise | 0.0165 | 0.06 | 0.06 | 0.0656 | -0.0086 | 0.01 | 0.06 | 0.08 | -0.03 | 0.06 | 0.13 | 0.16 |
| Surprise Percentage | 14.5374% | 46.1538% | 30% | 21.5506% | -5.7873% | 8.3333% | 25% | 30.7692% | -27.2727% | 50% | 260% | 55.1724% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.34 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ELAN
2026-04-16 15:40:01
Citi has reiterated its Buy rating on Elanco Animal Health (ELAN.US) and maintained its target price at $30. This indicates a continued positive outlook from the firm regarding the company's stock performance.
2026-04-16 15:40:00
Citigroup analysts have set a price target of $30.00 per share for Elanco Animal Health (NYSE:ELAN). This target suggests a potential upside for the stock based on the firm's analysis.
2026-04-16 11:39:29
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2026 financial results and host a conference call on Wednesday, May 6, 2026, at 8:00 a.m. Eastern time. The live webcast and replay will be accessible via the company's investor website. This announcement follows a consistent pattern of quarterly and annual earnings date confirmations, with analyst sentiment and impact noted as neutral.
2026-04-15 22:10:28
Elanco Animal Health Inc (ELAN) shares dropped 3.6% to $23.23 on April 15, 2026, positioning the stock as significantly overvalued according to GuruFocus's GF Value™ of $14.35. Despite an above-average GF Score™ of 72/100 and strong momentum (9/10), the low valuation rank (3/10) and historical P/E premium suggest a lack of safety margin for investors. There has also been no insider trading activity in the last three months, adding to the cautious outlook.
2026-04-15 18:10:28
Citigroup has initiated coverage on Elanco Animal Health (ELAN) with a 'Buy' rating and a price target of $30.00. Despite this positive analyst outlook, GuruFocus indicates that ELAN is significantly overvalued by 62.8% compared to its intrinsic GF Value™ of $14.35, raising concerns about potential downside risks for investors. The company, operating in the animal health sector, shows strong momentum but weak valuation metrics.
2026-04-15 11:16:00
The global animal health market is projected to grow from USD 40.1 billion in 2025 to USD 51.6 billion by 2034, driven by factors like increasing awareness of zoonotic diseases, technological advancements, and pet humanization. North America currently leads the market, while Asia Pacific and Europe show rapid growth. Key players include Bayer, Elanco, Merck, and Zoetis, focusing on innovations in veterinary drugs, diagnostics, and telemedicine.
